Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer Patients

NCT03601143 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT03601143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03601143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer Patients
Lead sponsor
Technical University of Munich
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2019
Completion date
December 31, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

castration-resistant prostate cancer